“Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study” (2023) Journal of Applied Oral Science, 31, p. e20220461. doi:10.1590/1678-7757-2022-0461 .